Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2015 June;63(3) > Minerva Cardioangiologica 2015 June;63(3):179-86

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

ORIGINAL ARTICLES  


Minerva Cardioangiologica 2015 June;63(3):179-86

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Impact of hemodialysis on the level of high-sensitivity cardiac troponins T in patients with end-stage renal disease

Levi M. 1, Bonenfant F. 1, Brouwers F. M. 2, Farand P. 1, Corbin F. 2, Nguyen M. 1

1 Division of Cardiology, Department of Medicine, Sherbrooke University Hospital Center, Sherbrooke, Quebec, Canada; 2 Division of Biochemistry, Sherbrooke University Hospital Center, Sherbrooke, Quebec, Canada


PDF  


AIM: The majority of patients with end-stage renal disease have chronically elevated concentrations of troponins, thus obscuring the diagnosis of myocardial infarction. We conducted a prospective study to examine the impact of hemodialysis on the level of high-sensitivity cardiac troponins T in asymptomatic patients with end-stage renal disease.
METHODS: High-sensitivity cardiac troponins T were measured in 43 patients, before and after three dialysis sessions, over a one week period.
RESULTS: Following dialysis, an average decrease of 7.6 pg/mL in high-sensitivity cardiac troponin T levels was observed which represents a 10.3% drop from baseline. Mutlivariable mixed linear regression models taking into account dialysis session (session 1, 2 or 3), sampling moment (before and after dialysis) and repeated measures on individuals revealed that the presence of coronary artery disease and elevated body mass index were associated with higher high-sensitivity cardiac troponin T levels when the other variables were held constant (CAD: β [fixed effect estimate]=31.13 pg/mL, P=0.022, 95%CI 4.46–57.80; body mass index: β=2.57 kg/m2, P=0.008, 95%CI 0.68-4.46). The significant fixed effect estimate for the interaction between gender and sampling moment indicated that the drop in high-sensitivity cardiac troponin T levels following dialysis was greater for women than for men (β=5.75, P=0.049, 95% CI 0.02-11.47). When controlling for the variables mentioned above, this analysis confirmed that hemodialysis accounted for an 11.31 pg/mL decrease in high-sensitivity cardiac troponin T levels (P<0.001, 95%CI -15.99 – -6.62) and that the values were higher in the first dialysis session than in the third (P=0.007; 95%CI 1.62–9.79). Ten patients (23%) were found to have no decrease or an increase in troponin levels after hemodialysis.
CONCLUSION: In stable asymptomatic patients with end-stage renal disease, we have shown that hemodialysis reduces the blood concentration of high-sensitivity cardiac troponins T by at least 10%. Further studies are needed to confirm these results and determine their prognostic significance.

top of page

Publication History

Cite this article as

Levi M, Bonenfant F, Brouwers FM, Farand P, Corbin F, Nguyen M. Impact of hemodialysis on the level of high-sensitivity cardiac troponins T in patients with end-stage renal disease. Minerva Cardioangiol 2015 June;63(3):179-86. 

Corresponding author e-mail

michel.nguyen@usherbrooke.ca